Camrelizumab (anti-PD-1)

Camrelizumab (anti-PD-1) is a humanized anti-PD-1 IgG4 antibody that blocks the binding of PD-L1 and PD-L2 to PD-1 with immune checkpoint inhibitory and antineoplastic activities, MW: 146.3 KD.
Supplier Selleck Chemicals
Product # A2016
Sku # A2016-1mg*5
Pricing 1mg*5, $707.00
Feedback